Process View
The process whose specific outcome is the progression of the cardiac myofibril over time, from its formation to the mature structure. A cardiac myofibril is a myofibril specific to cardiac muscle cells.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cardiac myofibril assembly"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TTN | titin | 1.000 | ||
| TRIM63 | tripartite motif containing 63 | 1.000 | ||
| NEB | nebulin | 0.960 | Human | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.953 | Mouse | |
| MYPN | myopalladin | 0.850 | ||
| ACTN2 | actinin, alpha 2 | 0.830 | ||
| OBSCN | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 0.788 | ||
| MYOZ1 | myozenin 1 | 0.698 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.565 | ||
| CAPN3 | calpain 3, (p94) | 0.541 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.320 | ||
| TCAP | titin-cap (telethonin) | 0.293 | ||
| TBX5 | T-box 5 | 0.235 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.215 | ||
| OBSL1 | obscurin-like 1 | 0.205 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.177 | Mouse | |
| HDAC4 | histone deacetylase 4 | 0.166 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.124 | ||
| PDGFC | platelet derived growth factor C | 0.086 | ||
| MYOG | myogenin (myogenic factor 4) | 0.075 | ||
| MRPL41 | mitochondrial ribosomal protein L41 | 0.070 | ||
| ATXN1 | ataxin 1 | 0.063 | ||
| MYOD1 | myogenic differentiation 1 | 0.061 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.054 | ||
| DES | desmin | 0.053 | ||
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.049 | ||
| ACTA1 | actin, alpha 1, skeletal muscle | 0.045 | ||
| PTEN | phosphatase and tensin homolog | 0.045 | ||
| KBTBD10 | kelch repeat and BTB (POZ) domain containing 10 | 0.044 | ||
| LAT | linker for activation of T cells | 0.040 | ||
| EGFR | epidermal growth factor receptor | 0.039 | ||
| FLNC | filamin C, gamma | 0.036 | ||
| ZYX | zyxin | 0.035 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.034 | ||
| SVIL | supervillin | 0.034 | ||
| ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) | 0.033 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.030 | ||
| ANK1 | ankyrin 1, erythrocytic | 0.026 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.022 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.021 | ||
| ACTN1 | actinin, alpha 1 | 0.020 | ||
| MYOCD | myocardin | 0.020 | ||
| DAZAP2 | DAZ associated protein 2 | 0.017 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.017 | ||
| ANKRD2 | ankyrin repeat domain 2 (stretch responsive muscle) | 0.016 | ||
| SLA | Src-like-adaptor | 0.014 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.014 | ||
| TNNI2 | troponin I type 2 (skeletal, fast) | 0.013 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.013 | ||
| NOMO1 | NODAL modulator 1 | 0.013 | ||
| INSR | insulin receptor | 0.013 | ||
| MYOZ2 | myozenin 2 | 0.012 | ||
| GFM1 | G elongation factor, mitochondrial 1 | 0.011 | ||
| KCNA5 | potassium voltage-gated channel, shaker-related subfamily, member 5 | 0.011 | ||
| XIRP2 | xin actin-binding repeat containing 2 | 0.011 | ||
| MEF2C | myocyte enhancer factor 2C | 0.011 | ||
| TNNI1 | troponin I type 1 (skeletal, slow) | 0.010 | ||
| GATA4 | GATA binding protein 4 | 0.010 | ||
| MKL2 | MKL/myocardin-like 2 | 0.010 |